“The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID : VEN/AZA effectively targets AML clones” (2022) Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022041. doi:10.4084/MJHID.2022.041.